An introduction to Exhalon, a spin-off from UVSQ / Foch Hospital / IHU SEPSIS, founded in 2025 by Stanislas Grassin-Delyle.
Université Paris-Saclay has featured an article on this startup, which combines high-resolution mass spectrometry and artificial intelligence to deliver ultra-fast, non-invasive diagnosis of respiratory diseases directly from exhaled breath.
Article published on January 16, 2026.
Latest news
How can rehabilitation be made clearer, more motivating, and more rewarding? This was the challenge at the heart of the HANDFUL workshop (HAnd-centric Neuromuscular Dexterity Training Interfaces for FUnctional Rehabilitation of Sepsis Patients' Limbs), conducted from October 2025 to April 2026 with...
Having earned her PhD in Microbiology in December 2025, Capucine reflects on her doctoral years at the IHU SEPSIS, within the Immunoanalysis Studies and Research Laboratory (LERI) of the Medicines and Healthcare Technologies Department (DMTS) at the CEA.